A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation

Reply to Topkan et al. Toxicities and prognostic factors in elderly HPV‐associated oropharyngeal cancer patients treated with radiotherapy or chemoradiotherapy

“…Our team has been part of a larger multinational effort to define the optimal chemotherapy regimens in elderly patients with locoregionally advanced HNSCC. 3,4 These efforts to leverage large datasets in a multicenter patient cohort will provide the power to determine important prognostic factors in HNSCC. Finally, outcomes after progression and the use of salvage therapies would be interesting but were beyond the scope of the current study.…”